scispace - formally typeset
C

Carlos Bloch

Researcher at Empresa Brasileira de Pesquisa Agropecuária

Publications -  108
Citations -  3665

Carlos Bloch is an academic researcher from Empresa Brasileira de Pesquisa Agropecuária. The author has contributed to research in topics: Antimicrobial peptides & Peptide sequence. The author has an hindex of 35, co-authored 107 publications receiving 3282 citations. Previous affiliations of Carlos Bloch include University of Brasília.

Papers
More filters
Journal ArticleDOI

Activity of wheat α‐amylase inhibitors towards bruchid α‐amylases and structural explanation of observed specificities

TL;DR: Improved structural understanding of the bases for the 0.19 structural family inhibitor specificity reported here may prove useful in the future for the rational design of inhibitors possessing altered inhibition characteristics.
Journal ArticleDOI

Inhibition of trypsin by cowpea thionin: characterization, molecular modeling, and docking.

TL;DR: The purification and characterization of a new thionin from cowpea with proteinase inhibitory activity is reported, with favorable interface characteristics comparable with structures of trypsin‐inhibitor complexes determined by X‐ray crystallography.
Journal ArticleDOI

Phylloseptins: a novel class of anti-bacterial and anti-protozoan peptides from the Phyllomedusa genus.

TL;DR: Six novel peptides called phylloseptins showing anti-bacterial and anti-protozoan activities were isolated from the skin secretion of the Brazilian tree-frogs and Phyllomedusa oreades, and Atomic force microscopy experiments indicated that the bacteriolytic properties of these peptides might be related to their disruptive action on the cell membrane.
Journal ArticleDOI

Identification of a novel storage glycine-rich peptide from guava (Psidium guajava) seeds with activity against Gram-negative bacteria

TL;DR: Amino acid sequencing revealed clear identity to the plant glycine-rich protein family, with Pg-AMP1 the first such protein with activity towards Gram-negative bacteria, and shows potential to contribute to development of novel antibiotics from natural sources.